 |
INTRODUCTION |
Saccharomyces cerevisiae shares many features of
Ca2+ homeostasis and signaling pathways with mammals (1).
Like other eukaryotes, yeast maintain a low resting free
Ca2+ concentration in their cytosol in the range of 50-200
nM (2-5). Considering that the total cellular
Ca2+ content is in the millimolar range, more than 99% of
the total cell-associated Ca2+ is either bound to proteins
within the cytosol or compartmentalized within intracellular
organelles. This remarkably tight control of free cytosolic
Ca2+ is a universal phenomenon among living organisms that
apparently relates to the low solubility of Ca2+
complexes of many phosphorylated metabolites (6). This tight control of
free cytosolic Ca2+ is also an essential feature of
Ca2+ signaling, where Ca2+-sensing proteins
like calmodulin utilize a transient increase in the steady-state
cytosolic Ca2+ concentration to activate various signal
transduction pathways (7).
The great majority of cellular Ca2+ is stored within
intracellular organelles in S. cerevisiae (8). The vacuole
is believed to contain the largest (~90%) reservoir of
Ca2+, where it is thought to reside primarily in a complex
with polyphosphate (9, 10). In contrast, the endoplasmic reticulum
(ER)1 and the Golgi apparatus
hold Ca2+ in a more readily mobilized form, which, together
with cytosolic Ca2+, is often referred to as the
exchangeable Ca2+ pool (11). Cytosolic Ca2+ can
be transported into the Golgi apparatus by the Ca2+-ATPase
Pmr1p (12-15) and possibly by another putative Ca2+ and
Mn2+ transporter, Ccc1p (16-18). Consistent with its
capacity to store Ca2+, a recent study demonstrated that
the Golgi apparatus can play a significant role in maintaining cellular
Ca2+ homeostasis under conditions where vacuolar
Ca2+ storage is compromised (4). Cytosolic Ca2+
can also be sequestered into the vacuole through the action of the
Ca2+-ATPase Pmc1p and the vacuolar
H+/Ca2+ exchanger Vcx1p/Hum1p (17, 19, 20). Of
these two transporters, Vcx1p has been shown to play a predominant role
in pumping cytosolic Ca2+ into the vacuole and restoring
basal cytosolic Ca2+ conditions following an increase in
cytosolic Ca2+ (5, 17, 20). The expression and function of
each of these Ca2+ transporters is regulated by
calcineurin, a highly conserved protein phosphatase that is activated
by Ca2+/calmodulin (4, 17, 20). While mitochondria have
been shown to play an important role in Ca2+ signaling in
mammalian cells, there is currently little or no evidence that
mitochondria play any role in Ca2+ sequestration in
S. cerevisiae (21, 22).
A number of stimuli can trigger a transient increase in the cytosolic
Ca2+ concentration in yeast. These stimuli include various
nutrients, mating pheromones, or a hypotonic shock (3, 23). While
glucose is frequently considered to be primarily a carbon and energy
source in yeast, it can also activate several signaling pathways in
yeast, including the RAS-cAMP pathway, phosphatidylinositol turnover, Ca2+ influx and efflux, and the glucose
repression/de-repression pathway (24). It is unclear whether these
distinct pathways are regulated by glucose, a glucose derivative, a
glycosylated protein, or by some other mechanism. Eilam and co-workers
(25, 26) have shown that glucose-stimulated Ca2+ uptake is
not controlled by changes in either the ATP level or by a
cAMP-dependent pathway. Interestingly, Glc-6-P has been
shown to stimulate the ATP-dependent transport of
Ca2+ into mammalian microsomes (27, 28), indicating that
glucose metabolites may directly influence Ca2+ transport
mechanisms in higher eukaryotes.
The biochemical pathways required to utilize glucose as a carbon and
energy source are highly conserved from bacteria to humans. A key
enzyme involved in this process is phosphoglucomutase (PGM; EC
2.7.5.1), which catalyzes the interconversion of Glc-1-P and Glc-6-P.
PGM acts at a key metabolic trafficking point that controls the
synthesis and degradation of carbohydrates. The direction of metabolic
flow through PGM depends on the available carbon source. Both the
degradation of glycogen and the metabolism of galactose as carbon
source require PGM activity to convert Glc-1-P to Glc-6-P. The Glc-6-P
produced can then be utilized in glycolysis and the pentose-phosphate
shunt. Conversely, PGM mediates the conversion of Glc-6-P to Glc-1-P
for sugar nucleotide (and ultimately, cell wall and glycogen) synthesis
in cells grown on glucose or non-fermentable carbon sources. S. cerevisiae contains genes encoding two isoforms of PGM. Expression
of the PGM2 gene, encoding the major isoform of PGM, is
greatly increased in galactose-containing media. In contrast, the
PGM1 gene expresses the minor isoform of PGM in a relatively
low, constitutive manner (29, 30). Yeast strains that lack both
isoforms of PGM are unable to grow when galactose is the sole carbon
and energy source (31). However, strains lacking both isoforms of PGM
can survive when grown on glucose, apparently because the conversion of
Glc-6-P to Glc-1-P can be supported to a small extent by related
enzymes such as phosphomannomutase and
N-acetylglucosamine-1-phosphate mutase (31, 32).
In the current study, we found that a mutant strain lacking the major
isoform of PGM (pgm2
) has a much higher rate
of Ca2+ uptake than an isogenic wild-type strain when grown
on galactose media. This increased rate of Ca2+ uptake
results in a 9-fold increase in total cellular Ca2+, but
does not reduce the fraction of Ca2+ located in the
exchangeable pool. Consistent with this observation, we could not
detect any defect in ER and Golgi functions that have previously been
shown to result from an inability to sequester Ca2+ into
these compartments in a pmr1
strain (12, 13, 33). Interestingly, this Ca2+ hyper-accumulation phenotype is
observed only when the pgm2
strain is grown in media
containing galactose as the sole carbon source, and correlates with the
accumulation of Glc-1-P under these growth conditions. These results
suggest that Glc-1-P (or a derivative) may regulate Ca2+
uptake from the environment.
 |
MATERIALS AND METHODS |
Strains Used--
Yeast strains used in this study are listed in
Table I. Sc252 and Sc451 were kindly
provided by J. Hopper (30). W303-1C and YRP032 were gifts from H. K. Rudolph (33). Yeast strains YDB0171, YDB0200, YDB0322, and YDB0201
were generated using a one-step gene replacement method (34). Briefly,
the PGM2 gene in YDB0171, YDB0322, and YDB0201 was disrupted
by the insertion of the LEU2 gene. A 1.5-kilobase pair
HpaI/HindIII DNA fragment containing most of the
structural gene of PGM2 in pDB0197 was removed by the
insertion of a BamHI/HindIII fragment containing the LEU2 gene from pJJ282 (35). The PGM1 genes in
YDB0200 and YDB0201 were disrupted by the insertion of the
URA3 gene. A 2-kilobase pair fragment of the PGM1
gene was generated by polymerase chain reaction using wild-type genomic
DNA as template. The forward primer used was DB225 (5'-CAA
GAC TCG AGA AGG GCG CAT CAC) and DB226 (5'-GAT CTT GAA TTC CTG TAC GGC TCT GC).
These primers contain XhoI and EcoRI restriction
endonuclease sites, respectively (underlined). The polymerase chain
reaction product was digested with EcoRI and XhoI
and cloned into a pBluescript KS II (+) plasmid. The 730-base pair
HindIII segment of the PGM1 gene was replaced by the HindIII fragment containing URA3 gene from
pJJ244 (35). The EcoRI/XhoI fragment containing
the disrupted pgm
1::URA3 was then used to
transform yeast. In all cases, the correct gene replacements were
confirmed by Southern blot analysis (data not shown). YDB0310 and
YDB0312 were generated by backcrossing the Sc451 strain with YR122 (36)
by standard methods (37).
Culture Medium--
Bacteria strains were grown on standard
media (38). Media for yeast growth were prepared as described (37). YP
media and synthetic media (SM) was supplemented with 2% glucose (YPD
or SMD) or 2% galactose (YPGal or SMGal) All media containing
Ca2+ or EGTA were routinely buffered with 40 mM
MES-Tris, pH 5.5 or 6.5 as specified. In all experiments, cultures were
grown for a minimum of 5-6 generations to an
A600 of
1.0.
Measurement of Total Cellular Ca2+ Levels, Cytosolic
Free Ca2+ Concentration, the Rate of Ca2+
Uptake, and the Efflux of Ca2+--
Total cellular
Ca2+ levels were measured as described earlier (4).
Briefly, 50-100 OD600 units of yeast cells grown in YPD or
YPGal were harvested and washed. The cell pellets were dried in a
Savant SpeedVac system and resuspended in 1 M HCl. The
total calcium levels were then measured by using a flame photometry method and expressed in moles per kilogram of dry mass.
The cytosolic free Ca2+ was measured by using an
aequorin-based method as described (4, 23). Briefly, the cells of the wild-type and pgm2
strains containing the
apoaequorin-expressing plasmid were grown in SMGal media supplemented
with the required amino acids. The cells were then harvested and loaded
with coelenterazine. For glucose- or galactose-stimulated
Ca2+ uptake, the cells were loaded with coelenterazine,
then were incubated without a carbon source for 2 h in SM medium
supplemented with 2 mM EGTA. To confirm that the glucose-
or galactose-stimulated increase in cytosolic Ca2+ was
dependent upon extracellular Ca2+, cells were incubated in
the presence or absence of 5 mM CaCl2 for 10 min prior to the addition of glucose or galactose. As previously reported (3), the increase in cytosolic Ca2+ was strictly
dependent upon extracellular Ca2+. In these experiments,
aequorin luminescence was measured using a Berthold Lumat 9050 luminometer. The data were recorded and transferred to a personal
computer for analysis. The cytosolic free Ca2+ was
calculated using a standard curve (4).
The rate of Ca2+ uptake was measured as described before
(14). The cells were harvested from an exponential phase culture, washed three times with distilled water, and resuspended in a buffer
containing 40 mM MES-Tris, pH 5.5, and 20 mM
D-glucose. The Ca2+ uptake experiment was then
initiated by the addition of [45Ca2+] to a
concentration of 1 µCi/ml. At the times indicated, aliquots were
filtered through a 0.45-µm Gelman filter pre-washed with buffer
containing 20 mM MgCl2 and 0.2 mM
LaCl3. The cells were then rapidly washed three times with
the same washing solution, and cell-associated
[45Ca2+] was determined by scintillation
counting. For the measurement of [45Ca2+]
uptake in glucose-starved cells, strains were grown in SMGal supplemented with required amino acids and then starved for carbon source for 2 h. The cells were then harvested, washed three times with water, and resuspended in 40 mM MES-Tris buffer, pH
5.5. Ca2+ uptake was initiated by the addition of 1%
glucose and 1 µCi of [45Ca2+]. At the
indicated times, cells were filtered and washed, and the
cell-associated radioactivity was determined by scintillation counting.
Nonspecific binding of [45Ca2+] to the cells
at the zero time point was subtracted.
The Ca2+ exchange experiments were done as described
previously (4, 19). Wild-type and pgm2
strains were grown
in YPGal for 5-6 generations in the presence of 10 µCi/ml
[45Ca2+] before harvest at logarithmic phase.
The cells were harvested by centrifugation at room temperature, washed
with YP medium, and then resuspended in YPGal plus 20 mM
CaCl2. After incubating at 30 °C for the time indicated,
aliquots of cells were harvested by rapid filtration, washed, and
processed for scintillation counting as described above.
Phosphoglucomutase Assay--
To assay for PGM activity, frozen
cell pellets were resuspended to 50 OD600 units/ml in assay
buffer (50 mM Bis-Tris, pH 6.0, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride). Cells were disrupted by
mechanical agitation with glass beads in a mini-bead beater (Biospec
Products). Assays were carried out on total cellular homogenates at
22 °C using a coupled enzyme assay as described (29). Specific
activity is expressed as micromoles of product formed/min/mg of
protein. Protein concentrations were determined by the method of
Bradford (39), with bovine serum albumin used to generate the standard curve.
Measure of the Metabolite Levels--
Extracts were made using a
method published previously (40). An aliquot of exponentially growing
yeast culture was filtered under vacuum through a 0.45-µm Gelman
filter. The wet weight of cells was rapidly determined, and the cells
were then frozen in liquid nitrogen. 3 ml of 3 M
HClO4 was added to the frozen cells, and they were then
ground in the presence of glass beads in a mortar cooled with liquid
nitrogen. The extract was centrifuged at 4 °C for 10 min at
10,000 × g, and the supernatant was neutralized by the
addition of 5 M KClO4. Glc-6-P levels in the
extract were measured using an assay coupled with Glc-6-P dehydrogenase
(41). Glc-1-P levels were measured similarly, with the addition of PGM. For the calculation of concentrations of each metabolite, it was assumed that 1.67 g of wet yeast contain 1 ml of cell volume
(40).
The levels of ATP, ADP, and AMP were measured by high performance
liquid chromatography analysis. Briefly, yeast extracts were resolved
using a Keystone Partisil-10 SAX column using a linear salt and pH
gradient from 5 to 750 mM
(NH4)H2PO4 and from pH 2.8 to 3.7, respectively, at a flow rate of 2 ml/min over 40 min. External
standards of known concentration were used to identify and quantitate
specific peaks that corresponded to each metabolite. The energy charge
of each strain was calculated as the sum of the ATP concentration plus
one-half the ADP concentration divided by the sum of the concentrations
of ATP, ADP, and AMP.
Analysis of Invertase Glycosylation and CpY*
Degradation--
Invertase glycosylation was determined from cells
labeled with [35S] methionine/cysteine
(Expre35S35S; NEN Life Science Products).
Immunoprecipitation was carried out using an invertase antibody (a gift
from Scott Emr) as described previously (42). To amplify the invertase
signal, strains containing pRB58 (43), a high copy invertase-expressing
plasmid, were grown in SMGal medium supplemented with the required
amino acids. 10 A600 units of cells were used
for the initial immunoprecipitation, followed by a second
immunoprecipitation using the same antibody. CpY* degradation was
assayed by a pulse-chase experiment as described previously (33),
except the cells were grown in SMGal medium.
 |
RESULTS |
Growth Phenotype of a pgm2
Yeast Strain--
PGM is a key
enzyme in glucose and galactose metabolism. In S. cerevisiae
there are two isoforms of PGM that are subject to distinct patterns of
regulation (29, 30). To better understand the physiological roles of
PGM, we constructed strains containing single pgm1
or
pgm2
knockouts, as well as a strain containing knockouts
of both genes (pgm1
/pgm2
). Initially, we compared the
growth of these strains on YPD and YPGal media. Consistent with the
results reported by Boles et al. (31), the
pgm1
, pgm2
, and pgm1
/pgm2
strains could all grow as well as the WT strain in YPD medium (data not
shown). On YPGal medium, the pgm1
strain grew as well as
the WT strain, while the growth of the pgm2
mutant was
somewhat reduced. In contrast, the pgm1
/pgm2
strain
could not grow on YPGal media, confirming that PGM activity is
essential for growth when galactose is the sole carbon source (31).
The pgm2
Strain Accumulates Glc-1-P When Grown on Galactose
Media--
PGM catalyzes the interconversion of Glc-6-P and Glc-1-P.
To determine how the pgm1
and pgm2
mutations affect the levels of sugar metabolites and energy metabolism
in cells grown on galactose media, we measured the specific activity of
PGM and the concentrations of Glc-1-P and Glc-6-P in strains containing
deletions of each PGM gene. As shown in Fig.
1A, inactivation of the
PGM2 gene greatly reduced the enzymatic activity of PGM in
galactose-grown cells. The specific activity of PGM in the WT strain
was about 0.9 µmol/min/mg of protein, while the pgm2
mutant was about 0.03 µmol/min/mg of protein. Thus, the
pgm2
mutant has 30-fold less PGM activity than the WT
strain.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Measurement of PGM specific activity, glucose
metabolites, and energy charge. Following growth in YPGal media to
mid-log phase, cells were harvested and extracts were prepared as
indicated under "Materials and Methods." A, PGM specific
activity in the WT and pgm2 strain. B, Glc-1-P
and Glc-6-P levels in the WT and pgm2 strain.
C, energy charge measured in the WT and pgm2
strains.
|
|
We next measured the levels of Glc-6-P and Glc-1-P in these strains. We
found that the steady-state levels of Glc-6-P and Glc-1-P in the WT
strain were 0.23 and 0.11 mM, respectively, when the cells
were grown in galactose-containing media. While the pgm2
strain had a level of Glc-6-P that was not significantly different from
the WT strain (0.20 mM), the Glc-1-P level in this strain
was increased to 0.75 mM (Fig. 1B). Hence, the
intracellular Glc-1-P concentration was 7-fold higher in the
pgm2
mutant than in the WT strain. These results suggest
that the limitation of PGM enzymatic activity caused by the
pgm2
mutation results in a metabolic bottleneck that
restricts the conversion of Glc-1-P to Glc-6-P. Like the Glc-6-P level,
the cellular energy charge in these strains was also found to be
similar (Fig. 1C), indicating that the pgm2
mutation did not cause a reduction in the ATP level when galactose was
utilized as the carbon source. Since the pgm2
strain
exhibits a moderately slower growth rate than the WT strain, these
results suggest that cellular growth may be limited by the ability to
generate a normal level of Glc-6-P (and ultimately, ATP). In contrast,
no significant differences in the levels of Glc-1-P, Glc-6-P, or the
energy charge were measured in these strains when they were grown in
YPD media (data not shown).
The pgm2
Strain Contains an Elevated Level of Total Cellular
Ca2+--
Previous studies have shown that glucose can
transiently stimulate Ca2+ uptake in glucose-deprived yeast
cells (3, 26). In addition, glucose can induce phosphatidylinositol
turnover and activation of the plasma membrane H+-ATPase in
glucose-deprived cells (24). While the mechanism by which glucose
activates these (and other) signaling pathways is not well understood,
it is thought that glucose or phosphorylated glucose derivatives may be
responsible. This led us to ask whether an alteration in the
concentration of glucose metabolites such as those observed in the
pgm2
strain when grown on YPGal could lead to an
imbalance in Ca2+ homeostasis. We initially measured the
total cellular Ca2+ level in the WT and pgm2
strains by flame photometry (4). We found that the total cellular
Ca2+ level in the WT strain was 2.85 mmol/kg dry weight
(Fig. 2A). In contrast, the
pgm2
mutant contained 25.83 mmol of Ca2+/kg
dry weight. Thus, the amount of total cellular Ca2+ in the
pgm2
strain was 9-fold higher than the wild-type strain in YPGal medium. We confirmed that the pgm2
strain had a
much higher level of total cellular Ca2+ by measuring the
accumulation of [45Ca2+] (data not shown).
When these strains were grown on YPD medium, we did not observe a
significant difference in the total cellular Ca2+ levels
between the WT and pgm2
strains, which contained 2.40 and
2.56 mmol of Ca2+/kg of dry weight, respectively (Fig.
2B). These results indicate that the increased accumulation
of cellular Ca2+ in the pgm2
mutant is
dependent upon utilization of galactose as the carbon source.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Total cellular Ca2+ accumulation
and uptake. A, total cellular Ca2+ in
strains grown in YPGal medium. B, total cellular
Ca2+ in strains grown in YPD medium. The indicated strains
were grown in standard YP medium supplemented with the indicated carbon
source to a density of ~1 OD600/ml. 100 OD600
units of cells were harvested and washed with fresh YP. Total
Ca2+ was then determined by flame photometry as described
(4). C, measurement of Ca2+ uptake rates. The
rate of [45Ca2+] uptake was measured in the
indicated strains over a time interval of 60 s as described under
"Materials and Methods."
|
|
The yeast PMR1 gene encodes a P-type Ca2+-ATPase
that localizes to the Golgi membrane (13). Previous studies have
documented the role of Pmr1p in Ca2+ transport into the
Golgi apparatus (12, 14) and in the maintenance of cellular
Ca2+ homeostasis in yeast (4). It has been reported that
the total cellular Ca2+ level in the pmr1
strain is increased 5-10-fold compared with the WT strain when grown
on YPD medium (14). Consistent with these reports, we found that the
pmr1
strain grown in YPD medium contained 20.91 mmol of
Ca2+/kg of dry weight, a level that was 8.7-fold higher
than the WT strain (Fig. 2B). When the pmr1
strain was grown in YPGal medium, we found that the total cellular
Ca2+ level was 7.85 mmol/kg dry mass, a level that was
2.7-fold lower than was observed in cells grown in YPD (Fig.
2A). This observation suggests that the carbon source may
also have a moderate effect on the absolute level of Ca2+
accumulation in the pmr1
strain. However, only the
pgm2
mutant showed a conditional defect in
Ca2+ accumulation that was evident only when a specific
carbon source was utilized.
Ca2+ Uptake Is Increased in the pgm2
Strain--
The massive Ca2+ accumulation observed when
the pgm2
mutant was grown in YPGal suggested that the
rate of Ca2+ uptake might also be increased. According to
Eilam and co-workers (44), the time course of Ca2+ influx
into yeast is composed of two components. The initial component
represents Ca2+ transported across the plasma membrane into
the cytosol. The second component represents the subsequent
distribution of the cytosolic Ca2+ into intracellular
organelles. These two components of Ca2+ uptake can be
determined by measuring [45Ca2+] uptake
during short and long time intervals, respectively. Yeast cells were
grown in YPGal and [45Ca2+] uptake
experiments were done as described (14, 44). We found that the initial
[45Ca2+] uptake rate in the
pgm2
strain was 5 times faster than was observed in the
WT strain, indicating that the elevated Ca2+ accumulation
in the pgm2
strain correlates well with an increase in
the rate of Ca2+ uptake across the cytoplasmic membrane
(Fig. 2C). By comparison, under the same conditions, we
found that Ca2+ uptake by the pmr1
strain was
only 2-fold greater than the WT strain. These values correlate well
with the total cellular Ca2+ levels measured in each of
these mutant strains.
The Fraction of Total Cellular Ca2+ in the Exchangeable
Pool Is Not Reduced in the pgm2
Strain--
Intracellular
Ca2+ in yeast exists in two kinetically distinguishable
pools, the exchangeable pool (representing Ca2+ in the
cytosol, ER, and Golgi apparatus) and the non-exchangeable pool
(representing Ca2+ in a more stable form within the
vacuole) (19, 45). To determine whether the partitioning of cellular
Ca2+ between the exchangeable and non-exchangeable pools is
altered in the pgm2
strain, cells growing in YPGal medium
were loaded for several generations with
[45Ca2+]. They were then harvested,
resuspended in YPGal containing 20 mM CaCl2,
and the radioactivity that remained associated with cells was
determined as a function of time (Fig.
3). Under these conditions, ~13% of
the total cellular [45Ca2+] was measured in
the exchangeable pool in WT cells after 40 min, while the remaining
87% of cellular [45Ca2+] was located within
the non-exchangeable pool (Fig. 3C).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Measurement of the exchangeable and
non-exchangeable pools by [45Ca2+]
release. The indicated strains were grown for five generations in
YPGal medium supplemented with [45Ca2+]. To
initiate the release of cellular [45Ca2+],
the strains were harvested, washed, and resuspended in YPGal
supplemented with 20 mM CaCl2. The cultures
were then incubated at 30 °C, and aliquots of cells were harvested
at the indicated times. The amount of cell-associated
[45Ca2+] was determined by liquid
scintillation counting. A, non-exchangeable pools, as
measured by [45Ca2+] associated with cells
after 40 min of incubation. B, exchangeable pools, as
measured by [45Ca2+] released from cells
after 40 min of incubation. C, percentage of cell-associated
[45Ca2+] that remained at the indicated
times.
|
|
Since the pmr1
strain contains a much larger absolute
amount of cellular Ca2+ than the WT strain, it also
contains more Ca2+ in both the non-exchangeable and
exchangeable pools (Fig. 3, A and B,
respectively). However, a much smaller fraction of the total cellular
Ca2+ (~7%) was found in the exchangeable pool in the
pmr1
mutant, consistent with its reduced ability to
transport Ca2+ into the ER and Golgi (Fig. 3C)
(12, 13, 33). Like the pmr1
strain, the
pgm2
strain also contains more total cellular Ca2+ than the WT strain. Consequently, the amount of
Ca2+ present in both the non-exchangeable and exchangeable
pools in this strain was also larger than was observed in the WT strain (Fig. 3, A and B). However, the absolute amount
of Ca2+ present in the exchangeable pool of the
pgm2
strain was >4-fold larger than was observed in the
pmr1
strain. Accordingly, the percentage of exchangeable
Ca2+ in the pgm2
mutant (~20%) was also
much higher than the pmr1
strain (and actually somewhat
higher than the WT strain). These results indicate that the
pgm2
strain does not have a diminished capacity to
maintain cellular Ca2+ in the exchangeable pool (which
includes the ER and/or Golgi), as was previously shown for the
pmr1
strain.
Galactose Metabolism Blocks Growth of a pgm2
/pmr1
Double
Mutant--
To gain a better understanding of the relationship between
Pgm2p and Pmr1p in the maintenance of Ca2+ homeostasis, we
generated a pgm2
/pmr1
double mutant. While strains
carrying the pgm2
or pmr1
mutations alone
were able to grow on YPGal plates, the pgm2
/pmr1
double mutant was unable to grow on galactose-containing media (Fig.
4A). Interestingly, the growth
inhibition of the pgm2
/pmr1
double mutant was relieved by the addition of 100 mM CaCl2 to the medium
(Fig. 4B). This conditional synthetic lethality associated
with combining the pmr1
and pgm2
mutations
suggests that the defects associated with these mutations are additive
in nature.

View larger version (194K):
[in this window]
[in a new window]
|
Fig. 4.
The pgm2 /pmr1 strain
is unable to grow in galactose-containing medium. The strains
indicated were plated on YPGal (A), YPGal plus 100 mM CaCl2 (B), YPLactate
(C), and YPGal plus lactate (D). The plates were
incubated at 30 °C for 5-7 days.
|
|
There are two possible reasons why the pgm2
/pmr1
double mutant is unable to grow on media containing galactose as carbon source. First, the cells may not grow because they are unable to
utilize galactose as the sole carbon and energy source available in the
medium. Alternatively, the metabolism of galactose may lead to such a
severe imbalance in cellular physiology that growth is inhibited. To
distinguish between these possibilities, the cells were inoculated onto
YP plates containing either lactate or lactate and galactose as carbon
source(s). We found that each of the mutant strains
(pgm2
, pmr1
, and
pgm2
/pmr1
) and the WT strain were able to grow when
lactate alone was provided as sole carbon source (Fig. 4C).
When both galactose and lactate were present, the WT and each of the
single mutants were again able to grow. In contrast, the
pgm2
/pmr1
double mutant was unable to grow under these
conditions (Fig. 4D), indicating that the metabolism of
galactose disrupted cellular physiology (presumably Ca2+
homeostasis) to the extent that growth could not occur even through the
utilization of lactate as carbon source.
The pgm2
Strain Is Sensitive to Cyclosporin A When Grown in
Galactose-containing Media--
Under normal conditions, the cytosolic
Ca2+ concentration in yeast is maintained within the
50-200 nM range (2, 3). Since we observed an elevated
level of total Ca2+ and exchangeable Ca2+ in
the pgm2
strain when grown in galactose-containing media, we next asked whether the signaling pathway mediated by calcineurin and
calmodulin was activated. To test this possibility, we asked whether
each of these strains could grow on YPGal medium in the presence of 10 µg/ml cyclosporin A (CsA), an inhibitor of calcineurin. We found that
growth of the WT and pmr1
strains was unaffected by CsA,
while growth of the pgm2
strain was completely inhibited (Fig. 5). These results suggests that the
pgm2
mutation may cause an imbalance in cellular
Ca2+ homeostasis to the extent that activation of the
calcineurin pathway is required to maintain growth of the
pgm2
strain in galactose-containing media.

View larger version (92K):
[in this window]
[in a new window]
|
Fig. 5.
Growth of the pgm2 strain
is inhibited by CsA. Strains were streaked onto YPGal
(A) and YPGal supplemented with 10 µg/ml CsA
(B).
|
|
The pgm2
Mutation Leads to Increased Sequestration of Cytosolic
Ca2+ into Intracellular Compartments--
In a previous
study, it was shown that the re-addition of glucose to glucose-starved
cells led to a transient increase in cytosolic Ca2+ that
was dependent upon the presence of extracellular Ca2+ (3).
Since our CsA experiment indicated that the pgm2
strain required constitutive calcineurin activity to grow in galactose media,
we next asked whether this state of calcineurin activation could reduce
or abolish the increase in cytosolic Ca2+ levels previously
shown to accompany the addition of glucose to glucose-starved cells. To
make these measurements, we utilized an aequorin reporter system (23,
46) that recently proved useful in measuring transient changes in the
cytosolic Ca2+ concentration of yeast (4, 5). An aequorin
expression plasmid was transformed into the WT and pgm2
strains, and cultures of each strain were grown in SMGal medium to
mid-log phase. The cells were then harvested and resuspended in SM
medium lacking a carbon source for 2 h. We found that the resting
concentration of cytosolic Ca2+ in the WT strain was ~100
nM. When glucose was injected into the chamber to a final
concentration of 1%, we found that the cytosolic Ca2+
began to rise after a lag of 40-60 s and reached a peak of ~340 nM within 2-3 min (Fig.
6A). The Ca2+
level then dropped over the next 5 min until it reached a basal cytosolic Ca2+ concentration similar to the level measured
before glucose addition.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
The pgm2 strain is
defective in glucose-induced Ca2+ signaling. The
carbon source re-added was 1% glucose (A) or 1% galactose
(B). Yeast cells of the wild-type or the pgm2
strain, which were transformed previously with apoaequorin-containing
plasmid, were grown in SMGal, loaded with coelenterazine, and starved
for carbon source for 2 h. The indicated carbon source was then
added (as indicated by the arrow). The rate of
[45Ca2+] uptake following the addition of 1%
glucose is shown in C.
|
|
When we repeated this protocol with the pgm2
strain, we
found that the unstimulated cytosolic Ca2+ concentration
after carbon source depletion was ~90 nM, slightly lower
than the WT strain. However, when glucose was added to the carbon
source-starved pgm2
strain, no increase in cytosolic
Ca2+ was observed. To confirm that this absence of
glucose-stimulated Ca2+ uptake was not due to the fact that
the strains were grown in SMGal medium, we repeated the experiment and
examined the effect of galactose addition following the starvation
period. With the WT strain, we measured a basal cytosolic
Ca2+ concentration of ~60 nM. When galactose
was added, we again observed a 40-60-s delay, followed by a rapid
increase in cytosolic Ca2+ that reached a peak of ~160
nM. With the pgm2
strain, we observed a
resting cytosolic Ca2+ concentration of ~50
nM (again, slightly lower than the WT strain). When
galactose was added to the starved pgm2
cells, we
observed a very slight increase in cytosolic Ca2+ to ~60
nM, but the response was still much smaller than was
observed in the WT strain (Fig. 6B).
The results of the above experiments indicate that the
pgm2
strain is either unable to carry out
Ca2+ uptake from the extracellular environment under these
conditions, or it removes Ca2+ from its cytosol so rapidly
that the cytosolic Ca2+ concentration cannot increase to
the level observed in the WT strain. To distinguish between these
possibilities, we used a similar experimental protocol to determine
whether [45Ca2+] uptake was altered in the
pgm2
strain. Cells were grown in SMGal medium, harvested,
and resuspended in SM lacking a carbon source for 2 h. The rate of
[45Ca2+] uptake was then measured upon the
re-addition of glucose to the medium. We found that both strains had
similar rates of [45Ca2+] uptake (Fig.
6C), indicating that the pgm2
strain was not
significantly different from the WT strain in its ability to take up
Ca2+ following carbon source starvation. We conclude that
the transient rise in cytosolic Ca2+ was not observed in
the pgm2
strain upon glucose addition because the
entering Ca2+ was rapidly sequestered into intracellular
compartments. This increased rate of Ca2+ sequestration is
presumably mediated by Ca2+ transporters activated by
calcineurin in response to the elevated influx of Ca2+ in
the pgm2
stain.
The pgm2
Mutation Does Not Affect
Ca2+-dependent ER and Golgi Functions--
The
PMR1 gene encodes a Ca2+-ATPase localized to the
Golgi membrane (12). Although a direct measurement of the Golgi
Ca2+ level has not been made in the pmr1
mutant, the size of its exchangeable Ca2+ pool is reduced
in a manner that is consistent with reduced Golgi Ca2+
levels. Furthermore, the pmr1
mutation results in
incomplete outer chain glycosylation of invertase, a process that is
carried out by enzymes in the Golgi compartment (12, 13). Recently, it
was shown that deletion of the PMR1 gene also results in a delayed degradation of CpY*, a mutant form of the vacuolar protein carboxypeptidase Y (CpY) that is unable to acquire a properly folded
conformation upon translocation across the ER membrane (33). As a
consequence, it is recognized by the quality control apparatus within
the ER and rapidly transported back out of the ER to proteosomes for
degradation (47, 48). The pgm2
mutant shares some
alterations in Ca2+ homeostasis with the pmr1
strain, such as an elevated total cellular Ca2+ level and
increased Ca2+ uptake. On the other hand, the
pgm2
mutant (unlike the pmr1
mutant)
retains a normal distribution of Ca2+ between the
exchangeable and non-exchangeable pools.
To determine whether the pgm2
mutation also affects the
retrograde transport of misfolded proteins from the ER like the
pmr1
mutation, we determined the rate of CpY* degradation
by pulse-chase analysis of strains grown on SMGal medium. The WT strain
was found to degrade CpY* with a half-life of 20 min, while the
degradation of CpY* in the pmr1
strain had a half-life of
~80 min (Fig. 7, A and
B). This delay in degradation in the pmr1
strain is similar to the previously reported decay kinetics of CpY* in
this mutant (33). In contrast, the degradation of CpY* in the
pgm2
strain occurred at a rate similar to the WT strain,
indicating that the pgm2
mutation did not affect the
retrograde transport of CpY* from the ER to the cytosol.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 7.
Measurement of CpY* degradation and invertase
glycosylation. A, the strains indicated were grown in
SMGal, labeled with [35S]methionine, and chased with an
excess of methionine and cysteine for the indicated times. CpY* was
analyzed by immunoprecipitation with antiserum specific to yeast CpY.
B, quantitation of [35S]methionine-labeled
CpY* that remained after the indicated chase period. C, the
strains indicated were labeled with [35S]methionine in
SMGal. Invertase was then immunoprecipitated with a rabbit polyclonal
antiserum and analyzed by SDS-polyacrylamide gel electrophoresis. The
secreted and ER forms of invertase are indicated.
|
|
Since the pmr1
mutation also results in incomplete outer
chain glycosylation of invertase during its transit through the Golgi
apparatus, we also examined the glycosylation state of invertase in the
pgm2
strain following growth on SMGal medium. As shown in
Fig. 7C, the pmr1
strain lacks the
heterogeneous, highly glycosylated form invertase that migrates as a
smear above the ER form. In contrast, invertase in the
pgm2
mutant was glycosylated in a manner similar to the
WT strain, indicating that glycosylation within the Golgi is not
significantly altered by the pgm2
mutation. We conclude
that the pgm2
mutation does not alter the
Ca2+ concentration within the ER and Golgi compartments to
the extent that these enzymatic processes are compromised.
 |
DISCUSSION |
The results of this study indicate that the loss of the major
isoform of PGM causes large alterations in cellular Ca2+
homeostasis and signaling in galactose-grown cells. Under these conditions, the pgm2
strain exhibited a much higher rate
of Ca2+ uptake and more total cellular Ca2+
than the WT strain. The pgm2
strain was unable to grow on
YPGal plates supplemented with CsA, suggesting that the activation of Ca2+ transporters by the calcineurin pathway may be
required to adequately sequester the large quantity of Ca2+
that enters the cytosol of these cells. Such an increased capacity to
rapidly remove cytosolic Ca2+ could also explain why the
pgm2
strain is unable to properly mediate the transient
increase in cytosolic Ca2+ that accompanies the addition of
glucose to glucose-starved cells as described in previous studies (3,
26). In contrast, we did not observe any of these
Ca2+-related alterations when the pgm2
strain
was grown in either glucose or lactate media. The pgm2
strain thus exhibits a carbon source-dependent defect in
both cellular Ca2+ homeostasis and signaling. Since the
normal enzymatic function of PGM is to inter-convert Glc-1-P and
Glc-6-P, the loss of the majority of cellular PGM activity could be
predicted to limit the conversion of Glc-1-P to Glc-6-P in cells grown
on galactose, resulting in a "metabolic bottleneck." Consistent
with this prediction, we found that the pgm2
strain
accumulates a large amount of Glc-1-P when grown on galactose media.
The simplest interpretation of these results is that the intracellular
level of Glc-1-P (or a related glucose metabolite) stimulates the
accumulation of Ca2+ in the pgm2
strain under
these conditions. Interestingly, we found that the total cellular
Ca2+ level in the pmr1
strain was 2.5-fold
higher when grown in YPD medium than in YPGal, providing further
evidence that glucose metabolites may play a more general role in
controlling cellular Ca2+ levels than was previously appreciated.
The PMR1 gene encodes a Ca2+-ATPase involved in
the transport of Ca2+ into the Golgi apparatus. Several of
the Ca2+-related defects of the pgm2
strain
grown in galactose-containing media are similar to those observed with
the pmr1
strain, including elevated Ca2+
uptake and accumulation (12-14). Durr and co-workers (33) proposed that Pmr1p also mediates the uptake of Ca2+ into the ER,
since the pmr1
strain also exhibits a defect in retrograde protein transport out of the ER. In certain mammalian cell
types, the depletion of Ca2+ stores within the ER has been
proposed to induce the synthesis of a diffusible molecule termed
calcium influx factor (CIF). This molecule is thought to stimulate the
uptake of Ca2+ across the plasma membrane to amplify and
prolong the propagation of the cytosolic Ca2+ signal.
Interestingly, the yeast pmr1
strain is missing the Ca2+-ATPase responsible for transporting Ca2+
into the ER and the Golgi apparatus, and it also exhibits an increased
rate of Ca2+ uptake and accumulation. This phenotype would
be predicted if the depletion of Ca2+ from the compartments
of the secretory pathway resulted in the production of a CIF-like
molecule. Consistent with this reasoning, a recent study found that
this strain produces a high level of a CIF-like activity (49). Several
groups have reported that CIF is a soluble molecule with a molecular
mass of
700 Da (49-51). Although the structure of CIF has not been
determined, it was suggested to contain hydroxyl groups on adjacent
carbons and a phosphate moiety (51, 52). The predicted molecular mass
and structural characteristics are consistent with the features
expected if CIF were related to (or derived from) a sugar phosphate or sugar nucleotide (53). This raises the possibility that Glc-1-P may be
a metabolic precursor in the CIF biosynthetic pathway.
While the increased rate of Ca2+ uptake and total cellular
Ca2+ levels in the pgm2
strain could be
attributable to a store depletion mechanism that involves a CIF-like
signaling molecule, other aspects of the phenotype of the
pgm2
strain are inconsistent with such a model. First,
our data indicate that the pgm2
strain, unlike the
pmr1
strain, contains a fraction of total cellular
Ca2+ in the exchangeable pool that is at least as large (if
not larger) than the exchangeable pool in the WT strain. This suggests
that the level of Ca2+ contained in the ER and the Golgi
apparatus is not significantly reduced. Consistent with this, we did
not observe any evidence of reduced Ca2+ levels within the
ER or Golgi apparatus of the pgm2
strain in functional
assays that measured retrograde transport of CpY* from the ER, or
invertase glycosylation in the Golgi apparatus. These results indicate
that the elevated rate of Ca2+ uptake in the
pgm2
strain is not coupled to a defect in filling the
Ca2+ stores within the ER and/or the Golgi apparatus.
Instead, it appears that the pmr1
and pgm2
mutations induce the uptake of Ca2+ in mechanistically
distinct ways. Since the pgm2
strain accumulates a high
level of Glc-1-P, we hypothesize that Glc-1-P accumulation may be
coupled to elevated Ca2+ uptake by some mechanism. It is
possible that the accumulation of Glc-1-P may bypass the need to
deplete ER or Golgi Ca2+ stores prior to increased
Ca2+ uptake. This could occur if an increased concentration
of Glc-1-P stimulates the synthesis of CIF in the absence of store
depletion, or if Glc-1-P directly stimulates the rate of
Ca2+ accumulation into one or more intracellular
compartments (such as the ER, Golgi apparatus, or vacuole). This latter
possibility would not be unprecedented, since it has been shown that
Glc-6-P can stimulate ATP-dependent Ca2+ uptake
into isolated mammalian microsomes (27, 28). The existence of a Glc-6-P
transporter in mammalian ER membranes is well established. While
Glc-6-P transporter activity in the ER is coupled to Glc-6-P phosphatase activity in the ER lumen of gluconeogenic tissues such as
liver, the much broader tissue distribution of the Glc-6-P transporter
suggests that it may also participate in another general cellular
process such as Ca2+ homeostasis (54). Consistent with
this, it has been shown that neutrophils and monocytes from patients
with Glc-6-P transporter deficiency are unable to efficiently sequester
Ca2+ (55). As would be predicted from our model that
Glc-1-P can also function in this way, it was recently found that
Glc-1-P can also stimulate the ATP-dependent uptake of
Ca2+ into isolated cardiac
microsomes.2
To better understand how Pgm2p and Pmr1p each influence cellular
Ca2+ homeostasis, we constructed a
pgm2
/pmr1
strain. To our surprise, the
pgm2
/pmr1
double mutant was unable to grow on YPGal
medium, even when an alternate carbon source (lactate) was present.
This suggests that the metabolism of galactose in the
pgm2
/pmr1
double mutant may cause such a severe
imbalance in ion homeostasis that cell growth is inhibited. This
finding again suggests that the pmr1
and
pgm2
mutations may increase Ca2+ uptake in
distinct ways, since the phenotypic consequences of combining these two
mutations were more severe than the phenotype of strains carrying
either mutation alone. Although our results indicate that the free
Ca2+ level within the ER and the Golgi apparatus is normal
in the pgm2
strain, we cannot exclude the possibility
that the elevated Ca2+ uptake associated with the
pgm2
mutation is caused by the inability to fill another
intracellular compartment (or subcompartment) with Ca2+. If
this were the case, the combination of the pgm2
and
pmr1
mutations could further compromise the ability to
adequately fill the effected compartments when grown in standard YPGal
medium (which contains only 0.3 mM Ca2+). Our
finding that the addition of 100 mM CaCl2 can
restore the growth of the pgm2
/pmr1
strain on this
growth medium is consistent with such a model. Clearly, further studies
are required to determine the mechanism that couples glucose metabolism
to Ca2+ homeostasis. The elucidation of this process may
provide important new insights into the control of Ca2+
homeostasis in yeast. Ultimately, it may also lead to a better understanding of human diseases such as diabetes that are also caused
by defects in glucose metabolism.